1 year return (CAGR)
-
Generate Biomedicines, Inc. Common Stock Exchange (NASDAQ, USD)
GENB
15.77
+2.17 (+16.43%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
1.97B
Price/Sales
60.77
Ent value
1.94B
Price/Book
4.33
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 13.89 |
| Daily high | 15.39 |
| Daily low | 13.71 |
| Daily Volume | 3.92M |
| All-time high | 20.38 |
| 1y analyst estimate | 27.00 |
| Beta | - |
| EPS (TTM) | -1.74 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| GENB | S&P500 | |
| Current price drop from All-time high | -22.62% | -1.25% |
| Highest price drop | -40.68% | -56.47% |
| Date of highest drop | 16 Oct 2026 | 9 Mar 2009 |
| Avg drop from high | -15.35% | -10.65% |
| Avg time to new high | 11 days | 12 days |
| Max time to new high | 46 days | 1805 days |
News
